Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report.

Fiche du document

Auteurs
Date

13 décembre 2022

Type de document
Périmètre
Langue
Identifiants
Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1186/s41824-022-00157-y

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36510100

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2510-3636

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_33D865F9723D6

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , CC BY 4.0 , https://creativecommons.org/licenses/by/4.0/

Mots-clés 0

177Lu-DOTATATE; Lymphopenia; Pancreatic NET; Tuberculosis

Sujets proches En

Case

Citer ce document

S. Boughdad et al., « Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report. », Serveur académique Lausannois, ID : 10.1186/s41824-022-00157-y

Métriques

Partage / Export

Résumé 0

We report the case of a 72-year-old woman who presented with tuberculous arthritis during the setting of 177 Lu-DOTATATE therapy for a grade-2 neuro-endocrine pancreatic tumor with liver metastases. We hypothesized that this recurrence might have been related to the occurrence of lymphopenia, which is common during PRRT. Indeed, though lymphopenia is frequently dismissed, it could lead to the development of opportunistic diseases and its severity should be examined, especially in case of abnormal clinical symptoms.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en